The immunological role of lipid transfer/metabolic proteins in liver transplantation tolerance

Transplant Immunology

Volumn 17, Issue 2, 2007, Pages 130-136

  Nakano, Toshiaki ^a   Chen, Chao Long ^a   Goto, Shigeru ^a,b   Lai, Chia Yun ^a   Hsu, Li Wen ^a   Kawamoto, Seiji ^c   Sasaki, Tetsuya ^c   Lin, Yu Chun ^a   Kao, Ying Hsien ^a   Ohmori, Naoya ^d   Goto, Takeshi ^d   Sato, Shuji ^d   Jawan, Bruno ^a   Ono, Kazuhisa ^c   Cheng, Yu Fan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b Iwao Hospital   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d JOSAI INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

Adiponectin; Apolipoprotein E; Immunosuppressive activity; Liver transplantation; Tolerance

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN E; CYCLOSPORIN A; LIPID;

ALLOGRAFT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT RECIPIENT; GRAFT SURVIVAL; IMMUNOREACTIVITY; LIPID TRANSPORT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MIXED LYMPHOCYTE REACTION; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RAT; TRANSPLANTATION TOLERANCE; UPREGULATION; WESTERN BLOTTING;

ADIPONECTIN; ANIMALS; APOLIPOPROTEINS E; CYCLOSPORINE; GLYCOSYLATION; GRAFT REJECTION; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIPID METABOLISM; LIVER; LIVER TRANSPLANTATION; MALE; MODELS, ANIMAL; PROGNOSIS; RATS; RATS, INBRED STRAINS; RECOMBINANT PROTEINS; TRANSPLANTATION TOLERANCE;

EID: 33846925943     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.09.004     Document Type: Article

References (40)

1. Kamada N., Davies H.S., and Roser B. Reversal of transplantation immunity by liver grafting. Nature 292 5826 (1981) 840-842
2. Kamada N., Davies H.S., Wight D., Culank L., and Roser B. Liver transplantation in the rat. Biochemical and histological evidence of complete tolerance induction in non-rejector strains. Transplantation 35 4 (1983) 304-311
3. Kamada N., Brons G., and Davies H.S. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 29 5 (1980) 429-431
4. Rasmussen A., Davies H.F., Jamieson N.V., Evans D.B., and Calne R.Y. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 59 6 (1995) 919-921
5. Abo T., Kawamura T., and Watanabe H. Physiological responses of extrathymic T cells in the liver. Immunol Rev 174 (2000) 135-149
6. Kamada N., and Wight D.G. Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation 38 3 (1984) 217-221
7. Kamada N., Shinomiya T., Tamaki T., and Ishiguro K. Immunosuppressive activity of serum from liver-grafted rats. Passive enhancement of fully allogeneic heart grafts and induction of systemic tolerance. Transplantation 42 6 (1986) 581-587
8. Sumimoto R., and Kamada N. Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation 50 4 (1990) 678-682
9. Nakano T., Kawamoto S., Lai C.Y., Sasaki T., Aki T., Shigeta S., et al. Liver transplantation-induced antihistone H1 autoantibodies suppress mixed lymphocyte reaction. Transplantation 77 10 (2004) 1595-1603
10. Nakano T., Kawamoto S., Lai C.Y., Hsu L.W., Lin Y.C., Sasaki T., et al. Characterization of immunosuppressive factors expressed in serum by rat tolerogenic liver transplantation. Transplant Proc 37 1 (2005) 80-81
11. Hsu L.W., Goto S., Nakano T., Lai C.Y., Kao Y.H., Lin Y.C., et al. The effects of anti-histone H1 antibody on immune cells responsible for rejection reaction. Mol Immunol 42 10 (2005) 1155-1164
12. Tsurufuji M., Ishiguro K., Shinomiya T., Uchida T., and Kamada N. Immunosuppressive activity of serum from liver-grafted rats: in vitro specific inhibition of mixed lymphocyte reactivity by antibodies against class II RT1 alloantigens. Immunology 61 4 (1987) 421-428
13. Lord R., Kamada N., Kobayashi E., Goto S., and Sunagawa M. Isolation of a 40 kDa immunoinhibitory protein induced by rat liver transplantation. Transpl Immunol 3 2 (1995) 174-179
14. Edwards-Smith C., Goto S., Lord R., Shimizu Y., Vari F., and Kamada N. Allograft acceptance and rejection, mediated by a liver suppressor factor, LSF-1, purified from serum of liver transplanted rats. Transpl Immunol 4 4 (1996) 287-292
15. Pan T.L., Wang P.W., Huang C.C., Goto S., and Chen C.L. Expression, by functional proteomics, of spontaneous tolerance in rat orthotopic liver transplantation. Immunology 113 1 (2004) 57-64
16. Pan T.L., Goto S., Lord R., Huang Y.C., Huang C.M., Wang P.W., et al. Proteome analysis in liver transplantation. Transplant Proc 33 1-2 (2001) 156
17. Quarfordt S.H., Oswald B., Landis B., Xu H.S., Zhang S.H., and Maeda N. In vivo cholesterol kinetics in apolipoprotein E-deficient and control mice. J Lipid Res 36 6 (1995) 1227-1235
18. Matsuzawa Y., Funahashi T., Kihara S., and Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24 1 (2004) 29-33
19. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 1 (1999) 79-83
20. Wulster-Radcliffe M.C., Ajuwon K.M., Wang J., Christian J.A., and Spurlock M.E. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem Biophys Res Commun 316 3 (2004) 924-929
21. Wolf A.M., Wolf D., Rumpold H., Enrich B., and Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 323 2 (2004) 630-635
22. Chudek J., Adamczak M., Karkoszka H., Budzinski G., Ignacy W., Funahashi T., et al. Plasma adiponectin concentration before and after successful kidney transplantation. Transplant Proc 35 6 (2003) 2186-2189
23. Bayes B., Lauzurica R., Granada M.L., Serra A., Bonet J., Fontsere N., et al. Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation. Transplantation 78 1 (2004) 26-30
24. Bakkaloglu S.A., Soylemezoglu O., Buyan N., Oktar S.O., Funahashi T., Pasaoglu H., et al. Adiponectin levels and arteriosclerotic risk factors in pediatric renal transplant recipients. Pediatr Transplant 10 2 (2006) 187-192
25. Kamada N., and Calne R.Y. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 28 1 (1979) 47-50
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 5259 (1970) 680-685
27. Wernette-Hammond M.E., Lauer S.J., Corsini A., Walker D., Taylor J.M., and Rall Jr. S.C. Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. J Biol Chem 264 15 (1989) 9094-9101
28. Aleshkov S.B., Li X., Lavrentiadou S.N., and Zannis V.I. Contribution of cysteine 158, the glycosylation site threonine 194, the amino-and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide beta (1-40). Biochemistry 38 28 (1999) 8918-8925
29. Shuvaev V.V., Fujii J., Kawasaki Y., Itoh H., Hamaoka R., Barbier A., et al. Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site. Biochim Biophys Acta 1454 3 (1999) 296-308
30. Mahley R.W., and Rall Jr. S.C. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1 (2000) 507-537
31. Greenow K., Pearce N.J., and Ramji D.P. The key role of apolipoprotein E in atherosclerosis. J Mol Med 83 5 (2005) 329-342
32. Grainger D.J., Reckless J., and McKilligin E. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J Immunol 173 10 (2004) 6366-6375
33. Tenger C., and Zhou X. Apolipoprotein E modulates immune activation by acting on the antigen-presenting cell. Immunology 109 3 (2003) 392-397
34. Okamoto Y., Kihara S., Funahashi T., Matsuzawa Y., and Libby P. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond) 110 3 (2006) 267-278
35. Louthan M.V., Barve S., McClain C.J., and Joshi-Barve S. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. J Pediatr 147 6 (2005) 835-838
36. Aygun C., Senturk O., Hulagu S., Uraz S., Celebi A., Konduk T., et al. Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease. Eur J Gastroenterol Hepatol 18 2 (2006) 175-180
37. Wolf A.M., Wolf D., Avila M.A., Moschen A.R., Berasain C., Enrich B., et al. Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice. J Hepatol 44 3 (2006) 537-543
38. Chen J., Tan B., Karteris E., Zervou S., Digby J., Hillhouse E.W., et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 49 6 (2006) 1292-1302
39. Fuglsang J., Skjaerbaek C., Frystyk J., Flyvbjerg A., and Ovesen P. A longitudinal study of serum adiponectin during normal pregnancy. BJOG 113 1 (2006) 110-113
40. Takatsuki M., Uemoto S., Inomata Y., Egawa H., Kiuchi T., Fujita S., et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 72 3 (2001) 449-454